Close Menu

NEW YORK (GenomeWeb) – An international team has developed a new set of polygenic risk scores (PRS) for estimating women's lifetime risk of developing breast cancer, including estrogen receptor-positive or ER-negative forms of the disease.

By bringing together array-based genotyping data for nearly 94,100 breast cancer cases and more than 75,000 controls enrolled through dozens of Breast Cancer Association Consortium studies, the researchers came up with several potential PRS focused on overall breast cancer risk or the risk of developing specific breast cancer subtypes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.

Jun
06
Sponsored by
NRGene & Illumina

This webinar will discuss the impact of affordable de novo genome assemblies on crop research.

Jun
18
Sponsored by
ArcherDX

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect.